(18)F‐FES PET/CT Influences the Staging and Management of Patients with Newly Diagnosed Estrogen Receptor‐Positive Breast Cancer: A Retrospective Comparative Study with (18)F‐FDG PET/CT

PURPOSE. We compared the clinical value of 16a‐18F‐fluoro‐17b‐estradiol ((18)F‐FES) positron emission tomography (PET)/computed tomography (CT) and (18)F‐fluoro‐2‐deoxy‐D‐glucose ((18)F‐FDG) PET/CT and investigated whether and how (18)F‐FES PET/CT affects the implemented management of newly diagnose...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Liu, Cheng, Gong, Chengcheng, Liu, Shuai, Zhang, Yingjian, Zhang, Yongping, Xu, Xiaoping, Yuan, Huiyu, Wang, Biyun, Yang, Zhongyi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6975963/
https://ncbi.nlm.nih.gov/pubmed/31337657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0096
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados